The Biotech Growth Trust PLC announced the appointment of Professor Dame Kay Davies and Mr. Andrew Joy as independent non-executive directors of the company, with immediate effect. Professor Dame Kay Davies is the Dr. Lee's Professor of Anatomy and Associate Head of the Medical Sciences Division at the University of Oxford. She is director of the MRC Functional Genomics Unit at Oxford and a governor of the Wellcome Trust. Mr. Joy is one of the founder Partners of Cinven Limited where he was a member of the Executive Committee and remains a member the Portfolio Review Committee which oversees all of Cinven's investments. Mr. Joy was formerly a Director of Hill Samuel Bank and Managing Director of Hill Samuel Development Capital. The board further announced that Mr. John Sclater, CVO, the Chairman of the company, will retire at the conclusion of the forthcoming Annual General Meeting. He will be succeeded as Chairman by Lord Waldegrave of North Hill.